Identifying Second Malignancies Using Monoclonal Antibodies
Author Information
Author(s): M Mottolese, I Venturo, M Rinaldi, M Lopez, G Bigotti, M Benevolo, PG Natali
Primary Institution: Regina Elena Cancer Institute
Hypothesis
Can selected combinations of monoclonal antibodies increase the accuracy of detecting second primary tumors in cytological specimens?
Conclusion
The use of monoclonal antibodies significantly improves the identification of second primary tumors compared to conventional cytology.
Supporting Evidence
- Immunocytochemical analysis of 334 specimens showed improved accuracy in identifying second primary tumors.
- 199 out of 243 effusions were identified as metastatic from the first tumor.
- 44 second primary tumors were identified with 84% correlation to clinical and pathological findings.
Takeaway
Doctors can use special antibodies to find new cancers in patients who have already had cancer, making it easier to spot these new tumors.
Methodology
The study analyzed 334 cytological specimens using immunocytochemical analysis with a panel of monoclonal antibodies.
Limitations
Some cases could not be diagnosed beyond general terms like 'adenocarcinoma' until histological examination was available.
Participant Demographics
Patients with a past history of malignancy, including various types of cancers.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website